● Pharmacogenetics
-
ALDH Kuumbwa kwemajini
Kit iyi inoshandiswa pakuona nzvimbo ye ALDH2 gene G1510A polymorphism muDNA yeropa revanhu.
-
Kuumbwa kweMajini eCYP2C9 evanhu neVKORC1
Kit iyi inoshanda pakuongorora polymorphism yeCYP2C9*3 (rs1057910, 1075A>C) uye VKORC1 (rs9923231, -1639G>A) muDNA yeropa rose remunhu.
-
Kuumbwa kweMajini eCYP2C19 eMunhu
Kit iyi inoshandiswa pakuongorora huwandu hwemajini eCYP2C19 muropa remunhu (in vitro qualitative detection) mu CYP2C19 genes CYP2C19*2 (rs4244285, c.681G>A), CYP2C19*3 (rs4986893, c.636G>A), CYP2C19*17 (rs12248560, c.806>T) mu genomic DNA yemasampuli eropa revanhu.
-
Human Leukocyte Antigen B27 Nucleic Acid
Kit iyi inoshandiswa pakuona DNA mumhando dze HLA-B*2702, HLA-B*2704 uye HLA-B*2705.
-
MTHFR Gene Polymorphic Nucleic Acid
Kit iyi inoshandiswa kuona nzvimbo mbiri dzekuchinja kweMTHFR gene. Kit iyi inoshandisa ropa rose remunhu semuyedzo wekuyedza kuti ipe ongororo yemhando yekuchinja kwemasero. Inogona kubatsira vanachiremba kugadzira hurongwa hwekurapa hwakakodzera hunhu hwakasiyana hwemunhu kubva pahuwandu hwemasero, kuitira kuti ive nechokwadi chekuti hutano hwevarwere hwakakwana.